A rapid method to determine the bactericidal activity of compounds against non-replicating Mycobacterium tuberculosis at low pH
Abstract
There is an urgent need for new anti-tubercular agents which can lead to a shortened treatment time by targeting persistent or non-replicating bacilli. In order to assess compound activity against non-replicating Mycobacterium tuberculosis, we developed a method to detect the bactericidal activity of novel compounds within 7 days. Our method uses incubation at low pH in order to induce a non-replicating state. We used a strain of M. tuberculosis expressing luciferase; we first confirmed the linear relationship between luminescence and viable bacteria (determined by colony forming units) under our assay conditions. We optimized the assay parameters in 96-well plates in order to achieve a reproducible assay. Our final assay used M. tuberculosis in phosphate-citrate buffer, pH 4.5 exposed to compounds for 7 days; viable bacteria were determined by luminescence. We recorded the minimum bactericidal concentration at pH 4.5 (MBC4.5) representing >2 logs of kill. We confirmed the utility of the assay with control compounds. The ionophores monensin, niclosamide, and carbonyl cyanide 3-chlorophenylhydrazone and the anit-tubercular drugs pretomanid and rifampicin were active, while several other drugs such as isoniazid, ethambutol, and linezolid were not.
02 /Specification & Classification
Click any tag to browse matching papers- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Phenylhydrazones are active against non-replicating Mycobacterium tuberculosis
S. A. Bonnett, D. Dennison, … T. Parish·PLOS ONEPeer-reviewed·Oct 17, 2018
- High-throughput Screening of Compounds against Autoluminescent Nonreplicating Mycobacterium tuberculosis under Diverse Conditions
Xirong Tian, Wan-Li Ma, … Tianyu Zhang·bioRxiv·Mar 10, 2024
- InhA inhibitors have activity against non-replicating Mycobacterium tuberculosis
L. Flint, A. Korkegian, T. Parish·bioRxiv·Aug 19, 2020
- Activity of a three-phage combination against Mycobacterium tuberculosis in disease-relevant conditions
Saskia Janssen, Sasha E. Larsen, … Jakko van Ingen·bioRxiv·May 11, 2026
- Netupitant Exhibits Potent Activity on Mycobacterium tuberculosis Persisters
Hassan E. Eldesouky, Richard M. Jones, … David R. Sherman·ACS Infectious DiseasesPeer-reviewed·Jul 18, 2025
- Construction of lux-based promoter-reporter platforms in Mycobacterium bovis BCG for screening of drug repurposing small-molecule compounds as new anti-tuberculosis drugs
L. Zhu, A. W.-t. Lee, … G. K. H. Siu·bioRxiv·Nov 5, 2021